Is a complete NXTC research report available?

No complete published report is available for NextCure, Inc. (NXTC) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

NextCure, Inc. (NXTC)

NASDAQ: NXTC · USD

$5.03

+0.01 (+0.2%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first NXTC analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	18.2M
Net income (ttm)	-54.7M
EPS (ttm)	-$15.3
Shares out	3.6M
Volume	883,068
Beta	1.42
Price target	$20.0	+297.6%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -54.7M
EPS (ttm): -$15.3
Market cap: 18.2M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All NXTC indicators

Market & fundamental data

Available fields

181

Groups with data

Currency

USD

Showing 181 of 181 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001661059
Company name	NextCure, Inc.
Country	United States
Country code	US
Cusip	65343E207
Employees	40
Employees Change	-3%
Employees Change Percent	-6.98
Enterprise value	$-6.6M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2019-05-09
Isin	US65343E2072
Last refreshed	2026-07-31
Market cap	$18.2M
Market cap category	Nano-Cap
Price	$5.03
Price currency	USD
Sector	Healthcare
Sector PE	45.21
Sector PE Fwd	23.64
Sic	2834
Symbol	NXTC
Website	https://www.nextcure.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-299.68%
FCF yield	-274.01%
P/B ratio	0.68x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-54.7M
Net Income Growth Quarters	3%
Net Income Growth Years	0%
Profit Per Employee	$-1.4M
ROA	-66.71
Roa5y	-30.93
ROCE	-180.5
ROE	-132.4
Roe5y	-56.24
ROIC	-75.14

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-4.01%
Cagr3y	-37.29%
Cagr5y	-43.08%
EPS Growth Quarters	3
EPS Growth Years	3
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$38M
Cash	$29.7M
Current Assets	$31.7M
Current Liabilities	$6.9M
Debt	$4.9M
Debt Equity	$0.18
Equity	$26.7M
Liabilities	$11.3M
Long Term Assets	$6.2M
Long Term Liabilities	$4.4M
Net Cash	$24.8M
Net Cash By Market Cap	$136
Net Cash Growth	-50.36%
Net Debt Equity	$-0.93
Tangible Book Value	$26.7M
Tangible Book Value Per Share	$7.41
WACC	9.51

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.61
Net Working Capital	$-3.9M
Quick ratio	4.42
Working Capital	$24.9M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-53%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-4.01%
200-day SMA	9.51
3Y total return	-75.34%
50-day SMA	3.91
50-day SMA vs 200-day SMA	50under200
5Y total return	-94.02%
All Time High	1,308
All Time High Change	-99.62%
All Time High Date	2019-11-05
All Time Low	1.55
All Time Low Change	224.52%
All Time Low Date	2026-06-26
ATR	0.94
Beta	1.42
Beta1y	1.11
Beta2y	0.64
Ch YTD	-64.55
High	5.26
High52	15.74
High52 Date	2025-11-24
High52ch	-68.04%
Low	4.4
Low52	1.55
Low52 Date	2026-06-26
Low52ch	224.52%
Ma50ch	28.81%
Price vs 200-day SMA	-47.11%
RSI	56.82
RSI Monthly	39.12
RSI Weekly	42.58
Sharpe ratio	0.68x
Sortino ratio	1.92
Total Return	-53%
Tr YTD	-64.55
Tr1m	187.43%
Tr1w	20.34%
Tr3m	-43.74%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	3
Analyst Count Top	0
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$-1.94
Operating Income	$-56.1M
Price target	$20
Price Target Change	$298

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	2,259,840%
Float Percent	62.56%
Shares Insiders	1.27%
Shares Institutions	33.61%
Shares Out	3,612,096
Shares Qo Q	31.6%
Shares Yo Y	53%
Short Float	58.58%
Short Ratio	0.23
Short Shares	36.65

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-51.9M
Adjusted OCF	-51,949,000
Average Volume	6,348,724.3x
Bv Per Share	7.41
Ch1m	187.4
Ch1w	20.34
Ch1y	-4.01
Ch3m	-43.74
Ch3y	-75.34
Ch5y	-94.02
Ch6m	-51.73
Change	0.2%
Change From Open	1
Close	5.02
Days Gap	-0.8
Depreciation Amortization	1,814,000
Dollar Volume	4,441,832
Earnings Date	2026-08-04
Earnings Time	amc
EBIT	$-56.1M
EBITDA	$-54.3M
EPS	$-15.32
F Score	1
FCF	$-50M
FCF EV Yield	758.58x
FCF Per Share	$-13.84
Financing CF	23,560,000
Fiscal Year End	December
Founded	2,015
Investing CF	19,762,000
Ipr	-66.47
Iprfo	-97.3
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Date	2025-07-14
Last Split Type	Reverse
Last10k Filing Date	2026-03-05
Ma150	9.12
Ma150ch	-44.85%
Ma20	4.15
Ma20ch	21.26%
Net CF	-6,660,000
Next Earnings Date	2026-08-10
Open	4.98
Optionable	No
Position In Range	73.26
Post Close	5.03
Postmarket Change Percent	-4.17
Postmarket Price	$4.82
Ppne	5,389,000
Price Date	2026-07-30
Ptbv Ratio	0.68
Relative Volume	0.14x
Share Based Comp	1,967,000
Tr6m	-51.73%
Us State	Maryland
Volume	883,068

NextCure, Inc. (NXTC)

Coverage state: Market snapshot only — no published research

Generate the first NXTC analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · NXTC

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All NXTC indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on NXTC

Frequently asked questions